The Alzheimer\'s disease market refers to the broader global industry focused on the development, production, and distribution of treatments and supportive solutions for Alzheimer\'s disease, a progressive neurodegenerative condition that impairs memory and cognitive function. This market includes pharmaceutical therapeutics aimed at slowing disease progression or managing symptoms, as well as related diagnostics and care pathways that help identify and monitor patients. The scope of this market includes drug discovery and clinical development, regulatory approval, manufacturing, commercialization and post-market support for patients and health care systems due to the aging population and increasing disease prevalence across the globe. The market also integrates advances in biologics, small-molecule therapies and personalized medicine approaches designed to address underlying disease mechanisms and improve patient outcomes.